Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Msci Inc (MSCI) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Msci Inc vs uniQure N.V. Ordinary Shares — how do they compare? Msci Inc trades at $562.23 (market cap $41.29B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Msci Inc is far larger — about 27.9× uniQure N.V. Ordinary Shares's market cap, and Msci Inc pays a 1.44% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Msci Inc for 83 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

MSCIQURE
Market Cap
$41.29B$1.48B
Volume
468,4362,488,780
Sector
FinancialsHealth
52-Week High
$643.83$70.59
52-Week Low
$511.84$9.03
Typical Hold Time
83 Days0 Days
Enterprise Value
$47.46B$728.62M
Dividend Yield
1.44%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Msci Inc

MSCI trades at $560.52, down 1.32% today, with strong profitability (40.73% net margin) and consistent revenue growth from $2.2B in 2022 to $3.1B in 2025. Recent Q2 2026 earnings missed expectations at $4.94 EPS, but Q1 and Q4 2025 beat. Technicals show a bullish moving average signal with RSI at 59.48 neutral, while analyst consensus is strongly bullish with a $701.71 price target. The company maintains robust cash flow from operations of $1.6B in 2025.

Outlook remains positive driven by recurring revenue streams and market position, though high valuation (P/E 31.06) and debt levels ($4.51B long-term) pose risks. The upcoming Q3 2026 earnings on October 20, 2026, is a key catalyst. Investors should weigh strong fundamentals against premium pricing and macroeconomic sensitivity.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSCI
5% Buy95% Sell
Avg holding period · 83 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Msci Inc

MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.

Read more on MSCI →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →